Total amount: € 0,00
Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1812
Department of Internal Medicine, University of Pisa, Pisa
Adverse outcomes of chronic kidney disease, including loss of kidney function and development of renal failure and cardiovascular disease, can often be prevented or delayed through early detection and treatment. Recent clinical practice guidelines of the American National Kidney Foundation are analyzed about early identification of patients with kidney disease, especially for risk factors and evaluation of laboratory measurements for clinical assessment. Primary care physicians need to get more involved in detecting kidney disease in its early stages such as in the preclinical stage called “at increased risk” and in stage 1. Each patient with kidney disease should have a clinical plan of action based on the stage of disease. All patients and persons at increased risk for kidney disease should undergo measurement and assessment for quantitative proteinuria (as a marker of kidney damage) and glomerular filtration rate estimated by prediction equations (as level of renal function).